Published: Jan 1989
| ||Format||Pages||Price|| |
|PDF (104K)||6||$25||  ADD TO CART|
|Complete Source PDF (4.2M)||6||$60||  ADD TO CART|
There exist significant gaps in our understanding of human health effects resulting from inhalation of low-level nitrogen dioxide. Controlled clinical studies provide an important approach for examining acute effects in potentially sensitive subgroups. Although the evidence is inconclusive in linking nitrogen dioxide (NO2) exposure with enhanced bronchoconstriction in asthmatics, a more consistent data base is emerging. As evaluation techniques improve, it is predicted that more significant changes in the range of 0.30 ppm NO2 will be found.
nitrogen dioxide, asthma, air pollution, inhalation toxicology, airway hyperreactivity
Professor of medicine and toxicology and co-director of Pulmonary Disease Unit, Department of Medicine and Toxicology, University of Rochester School of Medicine and Dentistry, Rochester, NY